The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Inhibition of toll‐like receptor 4 breaks the inflammatory loop in autoimmune destructive arthritis
Abstract
Objective: Degeneration of extracellular matrix of cartilage leads to the production of molecules capable of activating the immune system via Toll‐like receptor 4 (TLR‐4). The objective of this study was to investigate the involvement of TLR‐4 activation in the development and progression of autoimmune destructive arthritis. Methods: A naturally occurring TLR‐4 antagonist, highly purified lipopolysaccharide (LPS) from Bartonella quintana , was first characterized using mouse macrophages and human dendritic cells (DCs). Mice with collagen‐induced arthritis (CIA) and mice with spontaneous arthritis caused by interleukin‐1 receptor antagonist (IL‐1Ra) gene deficiency were treated with TLR‐4 antagonist. The clinical score for joint inflammation, histologic characteristics of arthritis, and local expression of IL‐1 in joints were evaluated after treatment. Results: The TLR‐4 antagonist inhibited DC maturation induced by Escherichia coli LPS and cytokine production induced by both exogenous and endogenous TLR‐4 ligands, while having no effect on these parameters by itself. Treatment of CIA using TLR‐4 antagonist substantially suppressed both clinical and histologic characteristics of arthritis without influencing the adaptive anti–type II collagen immunity crucial for this model. Treatment with TLR‐4 antagonist strongly reduced IL‐1β expression in articular chondrocytes and synovial tissue. Furthermore, such treatment inhibited IL‐1–mediated autoimmune arthritis in IL‐1Ra −/− mice and protected the mice against cartilage and bone pathology. Conclusion: In the present study, we demonstrate for the first time that inhibition of TLR‐4 suppresses the severity of experimental arthritis and results in lower IL‐1 expression in arthritic joints. Our data suggest that TLR‐4 might be a novel target in the treatment of rheumatoid arthritis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pathogen Recognition and Innate Immunity
Akira, S., Uematsu, S., & Takeuchi, O. (2006) · Cell · doi:10.1016/j.cell.2006.02.015 · Cited by 11,952
Akira, S., & Takeda, K. (2004) · Nature reviews. Immunology · doi:10.1038/nri1391 · Cited by 8,312
The Danger Model: A Renewed Sense of Self
Matzinger, P. (2002) · Science · doi:10.1126/science.1071059 · Cited by 4,205
Chromatin–IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors
Leadbetter, E. A., Rifkin, I. R., Hohlbaum, A. M., Beaudette, B. C., Shlomchik, M. J., & Marshak-Rothstein, A. (2002) · Nature · doi:10.1038/416603a · Cited by 1,900
Regulation of lung injury and repair by Toll-like receptors and hyaluronan
Jiang, D., Liang, J., Fan, J., Yu, S., Chen, S., Luo, Y., Prestwich, G. D., Mascarenhas, M. M., Garg, H. G., Quinn, D. A., et al. (2005) · Nature Medicine · doi:10.1038/nm1315 · Cited by 1,401
The Extra Domain A of Fibronectin Activates Toll-like Receptor 4
Okamura, Y., Watari, M., Jerud, E. S., Young, D. W., Ishizaka, S. T., Rose, J., Chow, J. C., & Strauss, J. F. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100099200 · Cited by 1,216
Schaefer, L., Babelova, A., Kiss, E., Hausser, H.-J., Baliova, M., Krzyzankova, M., Marsche, G., Young, M. F., Mihalik, D., Götte, M., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23755 · Cited by 850
Maturation Stages of Mouse Dendritic Cells in Growth Factor–dependent Long-Term Cultures
Winzler, C., Rovere, P., Rescigno, M., Granucci, F., Penna, G., Adorini, L., Zimmermann, V. S., Davoust, J., & Ricciardi-Castagnoli, P. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.2.317 · Cited by 849
Lau, C. M., Broughton, C., Tabor, A. S., Akira, S., Flavell, R. A., Mamula, M. J., Christensen, S. R., Shlomchik, M. J., Viglianti, G. A., Rifkin, I. R., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050630 · Cited by 812
Horai, R., Saijo, S., Tanioka, H., Nakae, S., Sudo, K., Okahara, A., Ikuse, T., Asano, M., & Iwakura, Y. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.2.313 · Cited by 749
Toll-like Receptor 2 (TLR2) and TLR4 Differentially Activate Human Dendritic Cells
Re, F., & Strominger, J. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105927200 · Cited by 691
Johnson, G. B., Brunn, G. J., Kodaira, Y., & Platt, J. L. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.10.5233 · Cited by 648
Reduced Myocardial Ischemia-Reperfusion Injury in Toll-Like Receptor 4-Deficient Mice
Oyama, J.-I., Blais, C., Liu, X., Pu, M., Kobzik, L., Kelly, R. A., & Bourcier, T. (2004) · Circulation · doi:10.1161/01.cir.0000112575.66565.84 · Cited by 621
Franchimont, D., Vermeire, S., El Housni, H., Pierik, M., Van Steen, K., Gustot, T., Quertinmont, E., Abramowicz, M., Van Gossum, A., Devière, J., et al. (2004) · Gut · doi:10.1136/gut.2003.030205 · Cited by 597
(2008) · Arthritis & Rheumatism · doi:10.1002/art.23363 · Cited by 505
Joosten, L. A. B., Helsen, M. M., Saxne, T., van de Loo, F. A. J., Heinegård, D. K., & van den Berg, W. B. (1999) · PubMed · Cited by 441
Self-citationJoosten, L. A. B., Helsen, M. M. A., Saxne, T., van de Loo, F. A. J., Heinegård, D., & van den Berg, W. B. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.9.5049 · Cited by 405
Self-citationJoosten, L. A. B., Helsen, M. M. A., van de Loo, F. A. J., & van den Berg, W. B. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390513 · Cited by 400
Self-citationBrentano, F., Schorr, O., Gay, R. E., Gay, S., & Kyburz, D. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21273 · Cited by 377
Hepatic Ischemia/Reperfusion Injury Involves Functional TLR4 Signaling in Nonparenchymal Cells
Tsung, A., Hoffman, R. A., Izuishi, K., Critchlow, N. D., Nakao, A., Chan, M. H., Lotze, M. T., Geller, D. A., & Billiar, T. R. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.11.7661 · Cited by 365
Roelofs, M. F., Joosten, L. A. B., Abdollahi‐Roodsaz, S., Van Lieshout, A. W. T., Sprong, T., van den Hoogen, F. H., Van Den Berg, W. B., & Radstake, T. R. D. J. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21278 · Cited by 334
Self-citationRadstake, T. R. D. J., Roelofs, M. F., Jenniskens, Y. M., Oppers‐Walgreen, B., van Riel, P. L. C. M., Barrera, P., Joosten, L. A. B., & van den Berg, W. B. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20678 · Cited by 331
Self-citationRegulation of Macrophage Chemokine Expression by Lipopolysaccharide In Vitro and In Vivo
Kopydlowski, K. M., Salkowski, C. A., Cody, M. J., van Rooijen, N., Major, J., Hamilton, T. A., & Vogel, S. N. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.3.1537 · Cited by 313
Van Der Heijden, I. M., Wilbrink, B., Tchetverikov, I., Schrijver, I. A., Schouls, L. M., Hazenberg, M. P., Breedveld, F. C., & Tak, P. P. (2000) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200003)43:3<593::aid-anr16>3.0.co;2-1 · Cited by 306
Intra-articularly localized bacterial DNA containing CpG motifs induces arthritis
Deng, G.-M., Nilsson, I.-M., Verdrengh, M., Collins, L. V., & Tarkowski, A. (1999) · Nature Medicine · doi:10.1038/9554 · Cited by 297
The role of dendritic cells in the induction and regulation of immunity to microbial infection
Reis e Sousa, C., Sher, A., & Kaye, P. (1999) · Current Opinion in Immunology · doi:10.1016/s0952-7915(99)80066-1 · Cited by 293
Mullarkey, M., Rose, J. R., Bristol, J., Kawata, T., Kimura, A., Kobayashi, S., Przetak, M., Chow, J., Gusovsky, F., Christ, W. J., et al. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.044487 · Cited by 292
Roelofs, M. F., Boelens, W. C., Joosten, L. A. B., Abdollahi-Roodsaz, S., Geurts, J., Wunderink, L. U., Schreurs, B. W., van den Berg, W. B., & Radstake, T. R. D. J. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.11.7021 · Cited by 278
Self-citationFort, M. M., Mozaffarian, A., Stöver, A. G., Correia, J. D. S., Johnson, D. A., Crane, R. T., Ulevitch, R. J., Persing, D. H., Bielefeldt-Ohmann, H., Probst, P., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.10.6416 · Cited by 216
Joosten, L. A. B., Koenders, M. I., Smeets, R. L., Heuvelmans-Jacobs, M., Helsen, M. M. A., Takeda, K., Akira, S., Lubberts, E., van de Loo, F. A. J., & van den Berg, W. B. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.11.6145 · Cited by 216
Self-citationChoe, J.-Y., Crain, B., Wu, S. R., & Corr, M. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021850 · Cited by 195
Loppnow, H., Libby, P., Freudenberg, M., Krauss, J. H., Weckesser, J., & Mayer, H. (1990) · Infection and Immunity · doi:10.1128/iai.58.11.3743-3750.1990 · Cited by 163
Su, S. B., Silver, P. B., Grajewski, R. S., Agarwal, R. K., Tang, J., Chan, C., & Caspi, R. R. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.10.6303 · Cited by 136
Rankin, J. A., Sylvester, I., Smith, S. M., Yoshimura, T., & Leonard, E. J. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114875 · Cited by 124
Horai, R., Nakajima, A., Habiro, K., Kotani, M., Nakae, S., Matsuki, T., Nambu, A., Saijo, S., Kotaki, H., Sudo, K., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci20742 · Cited by 122
Elimination of trace endotoxin protein from rough chemotype LPS
Manthey, C. L., & Vogel, S. N. (1994) · Journal of Endotoxin Research · doi:10.1177/096805199400100202 · Cited by 102
Lepper, P. M., Triantafilou, M., Schumann, C., Schneider, E. M., & Triantafilou, K. (2005) · Cellular Microbiology · doi:10.1111/j.1462-5822.2005.00482.x · Cited by 100
Arthritogenic Properties of Double-Stranded (Viral) RNA
Zare, F., Bokarewa, M. I., Nenonen, N. P., Bergström, T. B., Alexopoulou, L., Flavell, R. A., & Tarkowski, A. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.9.5656 · Cited by 97
Bartonella quintanaLipopolysaccharide Is a Natural Antagonist of Toll-Like Receptor 4
Popa, C. D., Abdollahi‐Roodsaz, S., Joosten, L. A. B., Takahashi, N., Sprong, T., Matera, G., Liberto, M. C., Focà, A., van Deuren, M., Kullberg, B. J., et al. (2007) · Infection and Immunity · doi:10.1128/iai.00237-07 · Cited by 88
Self-citationZähringer, U., Lindner, B., Knirel, Y. A., van den Akker, W. M. R., Hiestand, R., Heine, H., & Dehio, C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313370200 · Cited by 85
The distribution of fibronectin in the pannus in rheumatoid arthritis.
Scott, D. L., Delamere, J. P., & WALTON, K. W. (1981) · PubMed Central · Cited by 71
Walle, T., VARTIO, T., Helve, T., Virtanen, I., & Kurki, P. (1990) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.1990.tb02802.x · Cited by 32
Jelaska (2000) · Pure Amsterdam UMC · doi:10.1002/1529-0131(200010)43:10 · Cited by 2
Cited by
Korn, T., Bettelli, E., Oukka, M., & Kuchroo, V. K. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132710 · Cited by 4,873
Emerging Role of Endosomal Toll-Like Receptors in Rheumatoid Arthritis
Thwaites, R., Chamberlain, G., & Sacre, S. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00001 · Cited by 748
Midwood, K., Sacre, S., Piccinini, A. M., Inglis, J., Trebaul, A., Chan, E., Drexler, S., Sofat, N., Kashiwagi, M., Orend, G., et al. (2009) · Nature Medicine · doi:10.1038/nm.1987 · Cited by 703
TLR4 Signaling Pathway Modulators as Potential Therapeutics in Inflammation and Sepsis
Kuzmich, N., Sivak, K., Chubarev, V., Porozov, Y., Savateeva-Lyubimova, T., & Peri, F. (2017) · Vaccines · doi:10.3390/vaccines5040034 · Cited by 633
Endogenous toll‐like receptor ligands and their biological significance
Yu, L., Wang, L., & Chen, S. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01127.x · Cited by 532
Metadata
- Authors
- Abdollahi‐Roodsaz, S., Joosten, L. A. B., Roelofs, M. F., Radstake, T. R. D. J., Matera, G., Popa, C., van der Meer, J. W. M., Netea, M. G., & van den Berg, W. B.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2007-08-30
- Volume
- 56
- Issue
- 9
- Pages
- 2957-2967
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W1978025330
- Cited by
- 302
- References
- 43
- FWCI
- 8.88
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.